2002
DOI: 10.1023/a:1021477316559
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Platelet Activating Factor (PAF) is a very potent stimulant of various cell functions but little is known about the mechanisms responsible for its marked effect on endothelial permeability. An in vitro assay system was used to assess the direct effect of PAF on the permeability of a bovine aortic endothelial cell (BAEC) monolayer to albumin. PAF produced a small but not significant increase of the permeability of BAEC monolayer to albumin. However, pre-treatment of the monolayer with indomethacin (10 microM) r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…fibroblast growth factor 2 (basic; FGF2; 2.3-fold), platelet/endothelial cell adhesion molecule (PECAM1; 2.3-fold), vascular endothelial growth factor A (VEGFA; K2.7-fold) and vasohibin 2 (VASH2; K2.4-fold)). Interestingly, VEGFA mRNA has lower levels in IP samples, which could be a mechanism to reduce vascular permeability (Zachary 1998, Farmer et al 2002. Since many genes involved in the biological processes of ECM remodelling were also described in the context of angiogenesis, the regulation of vascular remodelling could also play a role in the release of foetal membranes.…”
Section: Genes Related To Immune Responsementioning
confidence: 99%
“…fibroblast growth factor 2 (basic; FGF2; 2.3-fold), platelet/endothelial cell adhesion molecule (PECAM1; 2.3-fold), vascular endothelial growth factor A (VEGFA; K2.7-fold) and vasohibin 2 (VASH2; K2.4-fold)). Interestingly, VEGFA mRNA has lower levels in IP samples, which could be a mechanism to reduce vascular permeability (Zachary 1998, Farmer et al 2002. Since many genes involved in the biological processes of ECM remodelling were also described in the context of angiogenesis, the regulation of vascular remodelling could also play a role in the release of foetal membranes.…”
Section: Genes Related To Immune Responsementioning
confidence: 99%